| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.2M | — | +191.9% |
| Cost of Revenue | $24.6M | — | +36.9% |
| R&D Expense | $21.2M | — | -20.7% |
| SG&A Expense | $40.0M | — | +35.3% |
| Operating Income | -$59.5M | — | +8.8% |
| Interest Expense | $11.1M | — | +9.7% |
| Pre-tax Income | -$70.7M | — | -4.1% |
| Income Tax | $863K | — | -61.2% |
| Net Income | -$71.6M | — | -2.0% |
| EPS (Basic) | -$0.27 | — | -3.8% |
| EPS (Diluted) | -$0.27 | — | -3.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $130.9M | +25.7% | +36.7% |
| Accounts Receivable | $27.7M | +15.1% | +93.2% |
| Inventory | $33.2M | +0.1% | +126.9% |
| Current Assets | $368.8M | -15.4% | -40.1% |
| Total Assets | $527.1M | -10.5% | -29.4% |
| Current Liabilities | $63.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$65.3M | — | +13.6% |
| Capital Expenditures | $2.7M | — | -67.4% |
| Investing Cash Flow | $96.2M | — | +261.5% |
| Financing Cash Flow | -$2.1M | — | — |
| Free Cash Flow | -$68.0M | — | +18.9% |
| -4.5% |
| Total Liabilities | $418.2M | +1.8% | +11.5% |
| Stockholders' Equity | $108.8M | -38.9% | -70.7% |